Annual Book Value
$83.81 M
-$85.99 M-50.64%
31 December 2023
Summary:
Halozyme Therapeutics annual book value is currently $83.81 million, with the most recent change of -$85.99 million (-50.64%) on 31 December 2023. During the last 3 years, it has fallen by -$67.24 million (-44.52%). HALO annual book value is now -66.33% below its all-time high of $248.89 million, reached on 31 December 2018.HALO Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$452.70 M
+$163.28 M+56.42%
30 September 2024
Summary:
Halozyme Therapeutics quarterly book value is currently $452.70 million, with the most recent change of +$163.28 million (+56.42%) on 30 September 2024. Over the past year, it has increased by +$203.52 million (+81.68%). HALO quarterly book value is now at all-time high.HALO Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Book Value Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.6% | +81.7% |
| 3 y3 years | -44.5% | +60.7% |
| 5 y5 years | -66.3% | +84.5% |
HALO Book Value High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -57.5% | at low | at high | +587.5% |
| 5 y | 5 years | -66.3% | at low | at high | +680.0% |
| alltime | all time | -66.3% | +358.0% | at high | +873.9% |
Halozyme Therapeutics Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $452.70 M(+56.4%) |
| June 2024 | - | $289.42 M(+62.8%) |
| Mar 2024 | - | $177.81 M(+112.2%) |
| Dec 2023 | $83.81 M(-50.6%) | $83.81 M(-66.4%) |
| Sept 2023 | - | $249.18 M(+65.0%) |
| June 2023 | - | $151.03 M(+129.4%) |
| Mar 2023 | - | $65.85 M(-61.2%) |
| Dec 2022 | $169.80 M(-13.8%) | $169.80 M(+75.1%) |
| Sept 2022 | - | $96.99 M(-66.9%) |
| June 2022 | - | $293.17 M(+12.6%) |
| Mar 2022 | - | $260.26 M(+32.1%) |
| Dec 2021 | $196.95 M(+30.4%) | $196.95 M(-30.1%) |
| Sept 2021 | - | $281.67 M(+135.2%) |
| June 2021 | - | $119.75 M(+77.2%) |
| Mar 2021 | - | $67.59 M(-55.2%) |
| Dec 2020 | $151.05 M(+64.6%) | $151.05 M(+52.6%) |
| Sept 2020 | - | $98.99 M(-6.2%) |
| June 2020 | - | $105.58 M(+81.9%) |
| Mar 2020 | - | $58.04 M(-36.7%) |
| Dec 2019 | $91.77 M(-63.1%) | $91.77 M(-62.6%) |
| Sept 2019 | - | $245.35 M(-5.7%) |
| June 2019 | - | $260.05 M(+0.0%) |
| Mar 2019 | - | $260.05 M(+4.5%) |
| Dec 2018 | $248.89 M(+19.4%) | $248.89 M(+3.8%) |
| Sept 2018 | - | $239.74 M(-6.0%) |
| June 2018 | - | $254.93 M(-3.8%) |
| Mar 2018 | - | $265.06 M(+27.2%) |
| Dec 2017 | $208.37 M(-741.5%) | $208.37 M(+187.8%) |
| Sept 2017 | - | $72.39 M(+24.5%) |
| June 2017 | - | $58.16 M(-199.4%) |
| Mar 2017 | - | -$58.50 M(+80.1%) |
| Dec 2016 | -$32.48 M(-175.5%) | -$32.48 M(+170.9%) |
| Sept 2016 | - | -$11.99 M(-220.9%) |
| June 2016 | - | $9.92 M(-66.3%) |
| Mar 2016 | - | $29.47 M(-31.5%) |
| Dec 2015 | $43.00 M(+4.0%) | $43.00 M(+35.2%) |
| Sept 2015 | - | $31.80 M(-36.7%) |
| June 2015 | - | $50.23 M(+33.8%) |
| Mar 2015 | - | $37.55 M(-9.2%) |
| Dec 2014 | $41.35 M(-306.9%) | $41.35 M(+3.5%) |
| Sept 2014 | - | $39.94 M(-27.8%) |
| June 2014 | - | $55.30 M(-17.2%) |
| Mar 2014 | - | $66.75 M(-433.9%) |
| Dec 2013 | -$19.99 M | -$19.99 M(+473.4%) |
| Sept 2013 | - | -$3.49 M(-131.3%) |
| June 2013 | - | $11.14 M(-64.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $31.68 M(-35.2%) |
| Dec 2012 | $48.85 M(+348.2%) | $48.85 M(-4.6%) |
| Sept 2012 | - | $51.19 M(-26.1%) |
| June 2012 | - | $69.23 M(-14.6%) |
| Mar 2012 | - | $81.06 M(+643.7%) |
| Dec 2011 | $10.90 M(-46.4%) | $10.90 M(-59.7%) |
| Sept 2011 | - | $27.06 M(+34.9%) |
| June 2011 | - | $20.05 M(+48.4%) |
| Mar 2011 | - | $13.52 M(-33.6%) |
| Dec 2010 | $20.35 M(+194.8%) | $20.35 M(-41.9%) |
| Sept 2010 | - | $35.00 M(-347.9%) |
| June 2010 | - | -$14.12 M(+342.3%) |
| Mar 2010 | - | -$3.19 M(-146.2%) |
| Dec 2009 | $6.90 M(-55.1%) | $6.90 M(-58.4%) |
| Sept 2009 | - | $16.60 M(-37.2%) |
| June 2009 | - | $26.43 M(+573.6%) |
| Mar 2009 | - | $3.92 M(-74.5%) |
| Dec 2008 | $15.38 M(-73.4%) | $15.38 M(-50.2%) |
| Sept 2008 | - | $30.89 M(-22.1%) |
| June 2008 | - | $39.65 M(-19.5%) |
| Mar 2008 | - | $49.27 M(-14.7%) |
| Dec 2007 | $57.77 M(+150.3%) | $57.77 M(-11.0%) |
| Sept 2007 | - | $64.91 M(-8.3%) |
| June 2007 | - | $70.76 M(+73.0%) |
| Mar 2007 | - | $40.90 M(+77.2%) |
| Dec 2006 | $23.08 M(+26.8%) | $23.08 M(+53.3%) |
| Sept 2006 | - | $15.05 M(+4.4%) |
| June 2006 | - | $14.42 M(-11.4%) |
| Mar 2006 | - | $16.28 M(-10.6%) |
| Dec 2005 | $18.21 M(+22.8%) | $18.21 M(+226.7%) |
| Sept 2005 | - | $5.57 M(-39.6%) |
| June 2005 | - | $9.22 M(-22.8%) |
| Mar 2005 | - | $11.95 M(-19.4%) |
| Dec 2004 | $14.82 M(+3865.8%) | $14.82 M(+726.5%) |
| Sept 2004 | - | $1.79 M(-63.5%) |
| June 2004 | - | $4.91 M(-29.4%) |
| Mar 2004 | - | $6.96 M(+1761.8%) |
| Dec 2003 | $373.80 K(-198.5%) | $373.80 K(+489.6%) |
| Sept 2003 | - | $63.40 K(-12.3%) |
| June 2003 | - | $72.30 K(-6.7%) |
| Mar 2003 | - | $77.50 K(-120.4%) |
| Dec 2002 | -$379.60 K(-1764.9%) | -$379.60 K(-387.1%) |
| Sept 2002 | - | $132.20 K(-8.3%) |
| June 2002 | - | $144.20 K(+339.6%) |
| Mar 2002 | - | $32.80 K |
| Dec 2001 | $22.80 K | - |
FAQ
- What is Halozyme Therapeutics annual book value?
- What is the all time high annual book value for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual book value year-on-year change?
- What is Halozyme Therapeutics quarterly book value?
- What is the all time high quarterly book value for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly book value year-on-year change?
What is Halozyme Therapeutics annual book value?
The current annual book value of HALO is $83.81 M
What is the all time high annual book value for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual book value is $248.89 M
What is Halozyme Therapeutics annual book value year-on-year change?
Over the past year, HALO annual book value has changed by -$85.99 M (-50.64%)
What is Halozyme Therapeutics quarterly book value?
The current quarterly book value of HALO is $452.70 M
What is the all time high quarterly book value for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly book value is $452.70 M
What is Halozyme Therapeutics quarterly book value year-on-year change?
Over the past year, HALO quarterly book value has changed by +$203.52 M (+81.68%)